| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.055 | 0.08 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.049 | 0.08 |